Cellcept and Cannabis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Cannabis (marijuana). Common drug interactions include anaemia among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Cannabis. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Cannabis?

Cannabis has active ingredients of marijuana. It is often used in stress and anxiety. eHealthMe is studying from 13,371 Cannabis users. Check the latest studies of Cannabis.



On Jul, 06, 2026

21 people who take Cellcept and Cannabis together, and have interactions are studied.

Cellcept and Cannabis drug interactions.

What are the common drug interactions of Cellcept and Cannabis, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  4. Autoimmune hepatitis
  5. Balance disorder
  6. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  7. Burning sensation
  8. Dysstasia (difficulty in standing)
  9. Emotional distress
  10. Erythema (redness of the skin)

male:

  1. Aggression
  2. Anaphylactic reaction (serious allergic reaction)
  3. Adrenogenital syndrome (group of inherited disorders that are characterized by enlargement of the adrenal glands)
  4. Communication disorder (speech and language disorder)
  5. Dysmorphism (difference of body structure that is suggestive of a congenital disorder)
  6. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  7. Iron deficiency anaemia
  8. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Premature baby

What are the common drug interactions of Cellcept and Cannabis, by age (0-1 to 60+)? *:

0-1:

  1. Adrenogenital syndrome (group of inherited disorders that are characterized by enlargement of the adrenal glands)
  2. Communication disorder (speech and language disorder)
  3. Dysmorphism (difference of body structure that is suggestive of a congenital disorder)
  4. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  5. Iron deficiency anaemia
  6. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  7. Premature baby

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  2. Weaning failure

60+:

  1. Pulmonary hypertension (increase in blood pressure in the lung artery)

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 13 people, 61.90%
  2. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  3. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 9.52%
  4. High Blood Cholesterol: 2 people, 9.52%
  5. Birth Control: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Cannabis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Cannabis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cannabis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cannabis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and marijuana (the active ingredients of Cellcept and Cannabis, respectively), and Cellcept and Cannabis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: